NCT04028765View on ClinicalTrials.gov

Pitocin or Oral Misoprostol for PROM IOL

PHASE4CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

August 12, 2019

Primary Completion Date

December 8, 2022

Study Completion Date

January 8, 2023

Conditions
PROM
Interventions
DRUG

Misoprostol

Oral misoprostol 50 mcg every 4 hours for up to 6 doses or until cervical ripening is no longer indicated

DRUG

Oxytocin

IV Oxytocin 2 milliunits (mU)/min, increased by 2mU/min q15 minutes per hospital protocol

Trial Locations (1)

19104

Hospital of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT04028765 - Pitocin or Oral Misoprostol for PROM IOL | Biotech Hunter | Biotech Hunter